XML 26 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:    
Net loss $ (360,014) $ (53,149)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 1,338,459 1,354,149
Stock compensation 184,447 159,682
Gain on sale of real estate assets (424,945) (446,653)
Gain on dissolution of partnership interests (302,831) 0
Bad debt expense 44,981 14,185
Income attributable to noncontrolling interests 478,107 311,061
Other assets (53,285) (355,334)
Accounts payable and accrued liabilities (1,072,870) (196,962)
Net cash (used in) provided by operating activities (167,951) 786,979
Cash flows from investing activities:    
Real estate acquisitions (1,781,300) [1] (1,139,715) [1]
Building and tenant improvements (906,493) [1] (347,496) [1]
Deferred leasing costs (190,436) (191,938)
Proceeds received sale of real estate assets 2,570,553 3,793,877
Restricted cash (6,710) (36,478)
Net cash (used in) provided by investing activities (314,386) 2,078,250
Cash flows from financing activities:    
Proceeds from mortgage notes payable 1,068,780 18,733,828
Repayment of mortgage notes payable (1,708,638) (21,477,318)
Repurchase of common stock - related parties (165,018) 0
Debt issuance costs (13,080) (252,977)
Contributions received from noncontrolling interests in excess of distributions paid (420,544) 378,036
Dividends paid (1,252,544) (1,142,191)
Net cash used in financing activities (2,491,044) (3,760,622)
Net decrease in cash and cash equivalents (2,973,381) (895,393)
Cash and cash equivalents:    
Beginning of year 10,207,001 10,746,536
Ending of year 7,233,620 9,851,143
Supplemental disclosure of cash flow information:    
Interest paid 1,172,542 1,330,377
Non-cash financing activities:    
Conversion of partnership interests into common stock 0 0
Reinvestment of cash dividend 975,909 995,046
Accrual of dividends payable 1,269,148 1,180,179
Stock issued for purchase of NTR, Inc. $ 0 $ 1,900,000
[1] Total consolidated capital expenditures are equal to the same amounts disclosed for total reportable segments.